Catalyst Pharmaceuticals (CPRX) Capital Expenditures Growth (3y) (2014 - 2026)
Catalyst Pharmaceuticals (CPRX) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Catalyst Pharmaceuticals |
3.84 Bn |
3.08 Bn |
134.92 Mn |
-28.54% |
| Date | Value |
|---|
| Mar 31, 2026 |
-28.54% |
| Dec 31, 2024 |
28.99% |
| Sep 30, 2024 |
56.17% |
| Jun 30, 2024 |
115.44% |
| Mar 31, 2024 |
-39.77% |
| Dec 31, 2021 |
-10.31% |
| Sep 30, 2021 |
43.00% |
| Jun 30, 2021 |
-56.24% |
| Dec 31, 2019 |
-27.07% |
| Sep 30, 2018 |
17.26% |
| Jun 30, 2018 |
119.42% |
| Sep 30, 2015 |
2,334.29% |
| Jun 30, 2015 |
-15.90% |
| Mar 31, 2015 |
16.67% |
| Dec 31, 2014 |
96.91% |
